A statistical analysis did not reveal any relationship between the score of CD20+, CD163+ and CD138 + immune cells and pathological features of DCIS: histological grade (p = 0.98, p = 0.621, p = 0.192, respectively) and biological subtype HER2-positive vs. HER2-negative (p = 0.848, p = 0.099, p = 0.217, respectively). Here, ERBB2 is linked to ductal breast carcinoma in situ.